KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Other financing activities (2016 - 2025)

Historic Other financing activities for Elevance Health (ELV) over the last 15 years, with Q4 2025 value amounting to $12.0 million.

  • Elevance Health's Other financing activities rose 27142.86% to $12.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $22.0 million, marking a year-over-year increase of 100000.0%. This contributed to the annual value of $22.0 million for FY2025, which is 100000.0% up from last year.
  • Per Elevance Health's latest filing, its Other financing activities stood at $12.0 million for Q4 2025, which was up 27142.86% from $21.0 million recorded in Q3 2025.
  • Elevance Health's Other financing activities' 5-year high stood at $171.0 million during Q1 2021, with a 5-year trough of -$160.0 million in Q2 2021.
  • Moreover, its 5-year median value for Other financing activities was $4.0 million (2024), whereas its average is $5.2 million.
  • As far as peak fluctuations go, Elevance Health's Other financing activities crashed by 45000.0% in 2024, and later surged by 200000.0% in 2025.
  • Elevance Health's Other financing activities (Quarter) stood at $19.0 million in 2021, then skyrocketed by 31.58% to $25.0 million in 2022, then crashed by 92.0% to $2.0 million in 2023, then plummeted by 450.0% to -$7.0 million in 2024, then soared by 271.43% to $12.0 million in 2025.
  • Its Other financing activities was $12.0 million in Q4 2025, compared to $21.0 million in Q3 2025 and $3.0 million in Q2 2025.